PDL BIOPHARMA, INC. Contracts & Agreements

159 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Description of Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
PDL BIOPHARMA, INC.
Biotechnology
2021
Capital Provision Agreement dated as of December 11, 2020 between the Company and Epps Investments LLC
Investment Agreements
PDL BIOPHARMA, INC.
2021
Settlement and Mutual Release Agreement among the Company, Samuel J. Wohlstadter, Nadine H. Wohlstadter, Hyperion Catalysis International, Wellstat Vaccines, LLC, Wellstat Immuno...
Settlement Agreements
PDL BIOPHARMA, INC.
Biotechnology
MD
2020
Asset Transfer Agreement dated as of August 11, 2020 between Defined Diagnostics, LLC (F/K/A Wellstat Diagnostics LLC) and the
PDL BIOPHARMA, INC.
Biotechnology
NY
2020
Commercial Sublease Agreement dated as of November 5, 2020 by and between RDH Investments LLC and the Company
Lease Agreements
PDL BIOPHARMA, INC.
2020
Separation and Distribution Agreement, dated as of September 30, 2020, by and between PDL BioPharma, Inc
Separation Agreements
PDL BIOPHARMA, INC.
2020
Transition Services Agreement, dated as of September 30, 2020, between PDL BioPharma, Inc. and LENSAR, Inc
Transition Agreements
PDL BIOPHARMA, INC.
Biotechnology
DE
2020
Tax Matters Agreement, dated as of September 30, 2020, between PDL BioPharma, Inc. and LENSAR, Inc
PDL BIOPHARMA, INC.
Biotechnology
DE
2020
Confidential Severance Agreement and Release of All Claims
Severance Agreements
PDL BIOPHARMA, INC.
Biotechnology
2020
Share Purchase Agreement between Bartleby Limited and the Company, dated as of July 30, 2020
Share Agreements
PDL BIOPHARMA, INC.
2020
2020 Annual Bonus Plan
Bonus & Incentive Agreements
PDL BIOPHARMA, INC.
Biotechnology
2020
Description of Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
PDL BIOPHARMA, INC.
2020
Fifth Amendment to Lease Agreement between Mountain Bluebird Investments, LLC and the Company, effective November 11, 2019
Lease Agreements
PDL BIOPHARMA, INC.
2020
Severance Plan adopted as of November 15, 2019
Severance Agreements
PDL BIOPHARMA, INC.
2020
Form of Restricted Stock Agreement (Amended 11/15/19)
Stock Agreements
PDL BIOPHARMA, INC.
Biotechnology
DE
2020
Form of Restricted Stock Agreement Amendment Acknowledgment
Stock Agreements
PDL BIOPHARMA, INC.
2020
Form of Stock Option Agreement (Amended 11/15/19)
Stock Agreements
PDL BIOPHARMA, INC.
2020
Form of Stock Option Agreement Amendment Acknowledgment
Stock Agreements
PDL BIOPHARMA, INC.
Biotechnology
2020
Form of Stock Option Grant Notice Supplement
Stock Agreements
PDL BIOPHARMA, INC.
Biotechnology
2020
Form of Nonstatutory Inducement Stock Option Agreement (Amended 11/15/19)
Stock Agreements
PDL BIOPHARMA, INC.
2020
Form of Nonstatutory Inducement Stock Option Grant Notice Supplement
Stock Agreements
PDL BIOPHARMA, INC.
Biotechnology
2020
Form of Inducement Restricted Stock Agreement (Amended 11/15/19)
Stock Agreements
PDL BIOPHARMA, INC.
Biotechnology
DE
2020
Wind Down Retention Plan effective as of December 21, 2019
Retention Agreements
PDL BIOPHARMA, INC.
Biotechnology
NV
2020
Cooperation and Support Agreement, dated as of February 27, 2020, by and among PDL BioPharma, Inc., Engine Capital, L.P. and its affiliates
Cooperation Agreements
PDL BIOPHARMA, INC.
2020
Indenture, dated September 17, 2019, between PDL, BioPharma, Inc., as Issuer and The Bank of New York Mellon Trust Company, N.A., as Trustee
Indenture Agreements
PDL BIOPHARMA, INC.
Biotechnology
NY
2019
Supplemental Indenture, dated September 17, 2019 by and between PDL BioPharma, Inc., as Issuer and The Bank of New York Mellon Trust Company, N.A., as Trustee
Indenture Agreements
PDL BIOPHARMA, INC.
2019
Form of Exchange Agreement
Exchange Agreements
PDL BIOPHARMA, INC.
Biotechnology
NY
2019
Confidential Severance Agreement and Release of All Claims
Severance Agreements
PDL BIOPHARMA, INC.
2019
Noden Settlement Letter and Supply Agreement Amendment
Settlement Agreements
PDL BIOPHARMA, INC.
2019
Offer Letter between the Company and Ed Imbrogno
PDL BIOPHARMA, INC.
2019
2019 Annual Bonus Plan
Bonus & Incentive Agreements
PDL BIOPHARMA, INC.
Biotechnology
2019
Securities Purchase Agreement
Purchase Agreements
PDL BIOPHARMA, INC.
Biotechnology
CA
2019
Executive Severance Plan and Schedule of Benefits
Severance Agreements
PDL BIOPHARMA, INC.
Biotechnology
NV
2019
Form of Director and Officer Indemnification Agreement
Indemnification Agreements
PDL BIOPHARMA, INC.
Biotechnology
2018
2018 Annual Bonus Plan
Bonus & Incentive Agreements
PDL BIOPHARMA, INC.
2018
Amendment No. 1 to Royalty Purchase and Sale Agreement and Bill of Sale between PDL Investment Holding, LLC and Depomed, Inc. and Depo DR Sub, LLC, dated August 2, 2018
Purchase Agreements
PDL BIOPHARMA, INC.
Biotechnology
2018
Fourth Amendment to Lease Agreement between 932936, LLC and the Company, effective December 1, 2017
Lease Agreements
PDL BIOPHARMA, INC.
Biotechnology
2018
Confidential Separation Agreement and Release of All Claims between Danny Hart and the Company, dated as of October 23, 2017
Separation Agreements
PDL BIOPHARMA, INC.
2017
Offer Letter between the Company and Dominique Monnet, executed August 31, 2017
PDL BIOPHARMA, INC.
2017
2017 Annual Bonus Plan
Bonus & Incentive Agreements
PDL BIOPHARMA, INC.
2017
2017/21 Long-Term Incentive Plan
Bonus & Incentive Agreements
PDL BIOPHARMA, INC.
2017
Third Amendment to Lease Agreement between 932936, LLC and the Company, effective May 27, 2014
Lease Agreements
PDL BIOPHARMA, INC.
Biotechnology
2017
Schedule of Amendment to Omitted Credit Agreements
Credit Agreements
PDL BIOPHARMA, INC.
2017
PDL BIOPHARMA, INC. Debt Securities Indenture Dated as of November 22, 2016 The Bank of New York Mellon Trust Company, N.A., as Trustee CROSS-REFERENCE TABLE This Cross-Reference...
Indenture Agreements
PDL BIOPHARMA, INC.
2016
PDL BIOPHARMA, INC. as Issuer AND THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A. as Trustee SUPPLEMENTAL INDENTURE Dated as of November22, 2016 2.75% Convertible Senior Notes due...
Indenture Agreements
PDL BIOPHARMA, INC.
Biotechnology
NY
2016
PDL BIOPHARMA, INC. 2.75% Convertible Senior Note due 2021
Note Agreements
PDL BIOPHARMA, INC.
2016
PDL BIOPHARMA, INC. (a Delaware corporation) $150,000,000 2.75% Convertible Senior Notes Due 2021 UNDERWRITING AGREEMENT Dated: November 16, 2016 PDL BIOPHARMA, INC. (a Delaware...
Underwriting Agreements
PDL BIOPHARMA, INC.
2016
PDL BIOPHARMA, INC. (a Delaware corporation) $150,000,000 2.75% Convertible Senior Notes Due 2021 UNDERWRITING AGREEMENT Dated: November 16, 2016 PDL BIOPHARMA, INC. (a Delaware...
Underwriting Agreements
PDL BIOPHARMA, INC.
Biotechnology
NY
2016
Schedule of Amendment to Omitted Credit Agreement
Credit Agreements
PDL BIOPHARMA, INC.
Biotechnology
2016
Pursuant to 17 CFR 240.24b-2, confidential information has been omitted in places marked * * * and has been filed separately with the Securities and Exchange Commission pursuant...
PDL BIOPHARMA, INC.
Biotechnology
NY
2016
_____________________________________ SUPPLY AGREEMENT (Tekturna, Rasilez) between NOVARTIS PHARMA AG AND NODEN PHARMA DAC...
Supply Agreements
PDL BIOPHARMA, INC.
2016
Noden Pharma DAC Investment and Stockholders Agreement
Investment Agreements
PDL BIOPHARMA, INC.
2016
ASSET PURCHASE AGREEMENT (Tekturna, Rasilez) between NOVARTIS AG, NOVARTIS PHARMA AG, SPEEDEL HOLDING AG, AND NODEN PHARMA DAC...
Purchase Agreements
PDL BIOPHARMA, INC.
Biotechnology
NY
2016
PDL BIOPHARMA, INC. 2016 Annual Bonus Plan
Bonus & Incentive Agreements
PDL BIOPHARMA, INC.
2016
PDL BIOPHARMA, INC. Amended and Restated 2016/20 Long-Term Incentive Plan
Bonus & Incentive Agreements
PDL BIOPHARMA, INC.
2016
Schedule of Amendment to Omitted Credit Agreements
Credit Agreements
PDL BIOPHARMA, INC.
2016
PDL BIOPHARMA, INC. Amended and Restated 2015 Annual Bonus Plan
Bonus & Incentive Agreements
PDL BIOPHARMA, INC.
2015
PDL BIOPHARMA, INC. Amended and Restated 2015/19 Long-Term Incentive Plan
Bonus & Incentive Agreements
PDL BIOPHARMA, INC.
2015
Pursuant to 17 CFR 240.24b-2, confidential information has been omitted in places marked * * * and has been filed separately with the Securities and Exchange Commission pursuant...
Exchange Agreements
PDL BIOPHARMA, INC.
2015
932 Southwood BoulevardIncline Village, NV 89451Phone: (775) 832-8500Fax: (775) 832-8502
PDL BIOPHARMA, INC.
Biotechnology
NV
2015
SECOND AMENDMENT TO OFFICE LEASE
Lease Agreements
PDL BIOPHARMA, INC.
2015
PDL BIOPHARMA, INC. AMENDED AND RESTATED 2005 EQUITY INCENTIVE PLAN ORIGINALLY EFFECTIVE: JUNE 8, 2005 AMENDED EFFECTIVE: JUNE 20, 2007 AND JUNE 4, 2009 AMENDMENT AND RESTATEMENT...
Bonus & Incentive Agreements
PDL BIOPHARMA, INC.
2015
PDL BIOPHARMA, INC. 2015 Annual Bonus Plan
Bonus & Incentive Agreements
PDL BIOPHARMA, INC.
2015
PDL BIOPHARMA, INC. 2015/19 Long-Term Incentive Plan
Bonus & Incentive Agreements
PDL BIOPHARMA, INC.
Biotechnology
2015
SECOND AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENT
Credit Agreements
PDL BIOPHARMA, INC.
2015
THIRD AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENT
Credit Agreements
PDL BIOPHARMA, INC.
2015
EXCHANGE AGREEMENT (Unrestricted Stock)
Exchange Agreements
PDL BIOPHARMA, INC.
2015
Schedule of Amendment to Omitted Credit Agreement
Credit Agreements
PDL BIOPHARMA, INC.
Biotechnology
2015
NOTE PURCHASE AGREEMENT dated April 1, 2014 between ACCEL 300, LLC and THE PURCHASER NAMED HEREIN NOTES DUE JUNE 1, 2029
Note Agreements
PDL BIOPHARMA, INC.
2014
PDL BIOPHARMA, INC. 2014/18 Long-Term Incentive Plan
Bonus & Incentive Agreements
PDL BIOPHARMA, INC.
Biotechnology
2014
FIRST AMENDMENT TO OFFICE LEASE
Lease Agreements
PDL BIOPHARMA, INC.
2014
FIRST AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENT
Credit Agreements
PDL BIOPHARMA, INC.
Biotechnology
NY
2014
PDL BIOPHARMA, INC. 2014 Annual Bonus Plan
Bonus & Incentive Agreements
PDL BIOPHARMA, INC.
2014
SECOND SUPPLEMENTAL INDENTURE dated as of February 28, 2014 among PDL BIOPHARMA, INC., as Issuer, and THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., as Trustee...
Indenture Agreements
PDL BIOPHARMA, INC.
Biotechnology
NY
2014
Form of Credit Agreement
Credit Agreements
PDL BIOPHARMA, INC.
Biotechnology
DE
2014
ROYALTY PURCHASE AND SALE AGREEMENT dated as of October 18, 2013 between DEPOMED, INC., DEPO DR SUB, LLC, as Seller, and PDL BIOPHARMA, INC., as Purchaser
Purchase Agreements
PDL BIOPHARMA, INC.
2014
PDL BIOPHARMA, INC. (a Delaware corporation) $260,870,000 4.00% ConvertibleSenior Notes Due 2018 UNDERWRITING AGREEMENT Dated: February 6, 2014 PDL BIOPHARMA, INC. (a Delaware...
Underwriting Agreements
PDL BIOPHARMA, INC.
Biotechnology
NY
2014
PDL BIOPHARMA, INC. Debt Securities Indenture Dated as of February 12, 2014 The Bank of New York Mellon Trust Company, N.A., as Trustee CROSS-REFERENCE TABLE This Cross-Reference...
Indenture Agreements
PDL BIOPHARMA, INC.
2014
PDL BIOPHARMA, INC. asIssuer AND THEBANK OF NEW YORK MELLON TRUST COMPANY, N.A. as Trustee SUPPLEMENTAL INDENTURE Dated as of February 12, 2014 $300,000,000 4.00%...
Indenture Agreements
PDL BIOPHARMA, INC.
Biotechnology
NY
2014
CREDIT AGREEMENT dated as of April 18, 2013 among AVINGER, INC. as the Borrower, PDL BIOPHARMA, INC., as the Lender, and PDL BIOPHARMA, INC., as the Agent
Credit Agreements
PDL BIOPHARMA, INC.
2013
PDL BIOPHARMA, INC. 2013 Annual Bonus Plan
Bonus & Incentive Agreements
PDL BIOPHARMA, INC.
Biotechnology
2013
PDL BIOPHARMA, INC. 2014 Long-Term Incentive Plan
Bonus & Incentive Agreements
PDL BIOPHARMA, INC.
2013
CREDIT AGREEMENT
Credit Agreements
PDL BIOPHARMA, INC.
Biotechnology
NY
2012
OFFICE LEASE
Lease Agreements
PDL BIOPHARMA, INC.
Biotechnology
2012
932 Southwood BoulevardIncline Village, NV89451Phone:(775) 832-8500Fax ###-###-####
PDL BIOPHARMA, INC.
Biotechnology
NV
2012
PDL BIOPHARMA, INC. 2013 Long-Term Incentive Plan
Bonus & Incentive Agreements
PDL BIOPHARMA, INC.
2012
PDLBIOPHARMA, INC. 2012 Annual Bonus Plan
Bonus & Incentive Agreements
PDL BIOPHARMA, INC.
2012
EXCHANGE AGREEMENT
Exchange Agreements
PDL BIOPHARMA, INC.
2012
PDL BIOPHARMA, INC. 2.875% SERIES 2012 CONVERTIBLE SENIOR NOTES DUE FEBRUARY 15,2015 INDENTURE DATEDAS OF JANUARY 5, 2012 THE BANK OF NEW YORK MELLON TRUST COMPANY, N. A. AS...
Note Agreements
PDL BIOPHARMA, INC.
2012
Indenture between the Company and The Bank of New York Mellon Trust Company, N.A., dated May 16, 2011
Indenture Agreements
PDL BIOPHARMA, INC.
Biotechnology
NY
2011
2012 Long-Term Incentive Plan
Bonus & Incentive Agreements
PDL BIOPHARMA, INC.
2011
Form of Executive Officer Severance Agreement
Severance Agreements
PDL BIOPHARMA, INC.
2011
PDL BIOPHARMA, INC. (a Delaware corporation) $135,000,000 3.75% Convertible Senior Notes Due 2015 UNDERWRITING AGREEMENT Dated: May 10, 2011 PDL BIOPHARMA, INC. (a Delaware...
Underwriting Agreements
PDL BIOPHARMA, INC.
2011
PDL BIOPHARMA, INC. as Issuer AND THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A. as Trustee SUPPLEMENTAL INDENTURE Dated as of May 16, 2011 $155,250,000 3.75% Convertible Senior...
Indenture Agreements
PDL BIOPHARMA, INC.
Biotechnology
NY
2011
Offer Letter between the Company and Danny Hart, dated January 11, 2010
PDL BIOPHARMA, INC.
Biotechnology
2011
PDLBIOPHARMA,INC. 2011Annual Bonus Plan
Bonus & Incentive Agreements
PDL BIOPHARMA, INC.
2011
PATENTLICENSE AGREEMENT between PROTEINDESIGN LABS, INC. and MEDIMMUNE,INC.
PDL BIOPHARMA, INC.
Biotechnology
CA
2011
PDL BIOPHARMA, INC. 2.875% CONVERTIBLE SENIOR NOTES DUE FEBRUARY 15, 2015 INDENTURE DATEDAS OF NOVEMBER 1, 2010 THE BANK OF NEW YORK MELLON TRUST COMPANY, N. A. AS TRUSTEE TABLE...
Indenture Agreements
PDL BIOPHARMA, INC.
2010
SETTLEMENT AGREEMENT
Settlement Agreements
PDL BIOPHARMA, INC.
Biotechnology
2010
AMENDED AND RESTATED PATENT LICENSING MASTER AGREEMENT (QUEEN PATENTS)
PDL BIOPHARMA, INC.
2010
- 1 -
PDL BIOPHARMA, INC.
Biotechnology
2010
PDLBIOPHARMA, INC. 2.875%CONVERTIBLE SENIOR NOTES DUE FEBRUARY15, 2015 INDENTURE DATED ASOF OCTOBER[], 2010 THE BANKOF NEW YORK MELLON TRUST COMPANY, N. A. ASTRUSTEE TABLEOF...
Indenture Agreements
PDL BIOPHARMA, INC.
2010
EXCHANGEAGREEMENT
Exchange Agreements
PDL BIOPHARMA, INC.
2010
PRIVATEPLACEMENT PURCHASE AGREEMENT
Purchase Agreements
PDL BIOPHARMA, INC.
Biotechnology
NY
2010
EXCHANGEAND PURCHASE AGREEMENT (RestrictedConvertible Notes)
Exchange Agreements
PDL BIOPHARMA, INC.
2010
EXCHANGEAGREEMENT
Exchange Agreements
PDL BIOPHARMA, INC.
2010
PDL BIOPHARMA, INC. 2010 Annual Bonus Plan
Bonus & Incentive Agreements
PDL BIOPHARMA, INC.
2010
PDL BIOPHARMA, INC. 2005 EQUITYINCENTIVE PLAN (AMENDED AND RESTATEDEFFECTIVE JUNE 4, 2009) PDL BIOPHARMA, INC.
PDL BIOPHARMA, INC.
Biotechnology
CA
2009
AMENDMENT NO. 1 TO SEPARATION AND DISTRIBUTION AGREEMENT
Separation Agreements
PDL BIOPHARMA, INC.
Biotechnology
DE
2009
CONFIDENTIAL PROVISIONS MARKED EXHIBIT 10.26 (CONFIDENTIAL) AMENDMENT NO. 2 TO THE PATENT LICENSING MASTER AGREEMENT
PDL BIOPHARMA, INC.
Biotechnology
2009
CONFIDENTIAL PROVISIONS MARKED
PDL BIOPHARMA, INC.
2009
CONFIDENTIAL PROVISIONS MARKED
PDL BIOPHARMA, INC.
2009
AMENDMENT TO THE RIGHTS AGREEMENT
PDL BIOPHARMA, INC.
2009
Separation and Distribution Agreement between PDLBioPharma, Inc., a Delawarecorporation and FacetBiotech Corporation, a Delawarecorporation Dated as of December17, 2008
Separation Agreements
PDL BIOPHARMA, INC.
2008
Transition Services Agreement PDL BioPharma, Inc., a Delaware corporation and Facet Biotech Corporation, a Delaware corporation Dated as of December 18, 2008
Transition Agreements
PDL BIOPHARMA, INC.
Biotechnology
2008
TaxSharing and Indemnification Agreement
Indemnification Agreements
PDL BIOPHARMA, INC.
2008
CONFIDENTIAL SEPARATION AGREEMENTAND GENERAL RELEASE
Separation Agreements
PDL BIOPHARMA, INC.
2008
CONFIDENTIALPROVISIONS REDACTED
PDL BIOPHARMA, INC.
2008
PDLBIOPHARMA, INC. RETENTIONAND SEVERANCE PLAN FOR CHIEFEXECUTIVE OFFICER
Severance Agreements
PDL BIOPHARMA, INC.
Biotechnology
CA
2008
ASSET PURCHASE AGREEMENT BY AND BETWEEN PDL BIOPHARMA, INC.,
Purchase Agreements
PDL BIOPHARMA, INC.
Biotechnology
CA
2007
FIRST AMENDMENT TO COLLABORATION AGREEMENT
Collaboration Agreements
PDL BIOPHARMA, INC.
Biotechnology
2007
(2002 Outside Directors Stock Option Plan)
Stock Agreements
PDL BIOPHARMA, INC.
Biotechnology
CA
2007
(1999 Stock Option Plan)
Stock Agreements
PDL BIOPHARMA, INC.
2007
PDL BioPharma, Inc. 2005 Equity Incentive Plan
Bonus & Incentive Agreements
PDL BIOPHARMA, INC.
Biotechnology
CA
2007
PDL BioPharma, Inc. 2005 Equity Incentive Plan
Bonus & Incentive Agreements
PDL BIOPHARMA, INC.
2007
PDL BIOPHARMA, INC. AND MELLON INVESTOR SERVICES, LLC as Rights Agent RIGHTS AGREEMENT Dated as of August 25, 2006 TABLE OF CONTENTS
Registration Rights Agreements
PDL BIOPHARMA, INC.
2006
PROTEIN DESIGN LABS, INC. 1999 STOCK OPTION PLAN
Stock Agreements
PDL BIOPHARMA, INC.
2006
PROTEIN DESIGN LABS, INC. 1999 NONSTATUTORY STOCK OPTION PLAN
Stock Agreements
PDL BIOPHARMA, INC.
2006
PROTEIN DESIGN LABS, INC. 1999 NONSTATUTORY STOCK OPTION PLAN
Stock Agreements
PDL BIOPHARMA, INC.
2006
PDL BIOPHARMA, INC. STOCK OPTION AGREEMENT (INCENTIVE)
Bonus & Incentive Agreements
PDL BIOPHARMA, INC.
2006
PDL BIOPHARMA, INC. STOCK OPTION AGREEMENT (NONSTATUTORY)
Stock Agreements
PDL BIOPHARMA, INC.
2006
PDL BIOPHARMA, INC. STOCK OPTION AGREEMENT (NONSTATUTORY)
Stock Agreements
PDL BIOPHARMA, INC.
2006
PDL BIOPHARMA, INC. NOTICE OF GRANT OF STOCK OPTION
Stock Agreements
PDL BIOPHARMA, INC.
2006
PDL BIOPHARMA, INC. STOCK OPTION AGREEMENT
Stock Agreements
PDL BIOPHARMA, INC.
2006
PDL BIOPHARMA, INC. NOTICEOF GRANT OF RESTRICTED STOCK AWARD
Stock Agreements
PDL BIOPHARMA, INC.
2006
PDL BIOPHARMA, INC. RESTRICTEDSTOCK AGREEMENT
PDL BIOPHARMA, INC.
2006
SUBLEASE
Lease Agreements
PDL BIOPHARMA, INC.
2006
TRIPLE NET SPACE LEASE between PACIFIC SHORES INVESTORS LLC, as
Lease Agreements
PDL BIOPHARMA, INC.
2006
TRIPLE NET SPACE LEASE between PACIFIC SHORES INVESTORS LLC, as
Lease Agreements
PDL BIOPHARMA, INC.
2006
Exhibit 10.54 to Form 10-K CONFIDENTIAL PROVISIONS REDACTED
PDL BIOPHARMA, INC.
2006
Exhibit 10.55 to Form 10-K CONFIDENTIAL PROVISIONS REDACTED
PDL BIOPHARMA, INC.
Biotechnology
2006
AMENDED AND RESTATED CONSULTING AGREEMENT
Consulting Agreements
PDL BIOPHARMA, INC.
Biotechnology
CA
2006
SYNTEX (U.S.A.) INC. - AMERICAN HOME PRODUCTS CORPORATION SUBLICENSE AND SUPPLY AGREEMENT DATED SEPTEMBER 1, 1993 RE: NICARDIPINE IV TABLE OF CONTENTS
Supply Agreements
PDL BIOPHARMA, INC.
2005
ASSETPURCHASE AGREEMENT CENTOCOR,INC (SELLER) ESPPHARMA, INC. (BUYER) January 31,2005
PDL BIOPHARMA, INC.
Biotechnology
NY
2005
AMENDEDAND RESTATED WORLDWIDE AGREEMENT
PDL BIOPHARMA, INC.
Biotechnology
CA
2005
ICOS CORPORATION MANUFACTURING AGREEMENT
PDL BIOPHARMA, INC.
Biotechnology
2005
PROTEINDESIGN LABS, INC. 2.00%CONVERTIBLE SENIOR NOTES DUE FEBRUARY 15, 2012 INDENTURE DATEDAS OF FEBRUARY 14, 2005 J.P.Morgan Trust Company, National Association, ASTRUSTEE
Indenture Agreements
PDL BIOPHARMA, INC.
2005
Protein Design Labs, Inc. 2.00% Convertible Senior Notesdue 2012 RegistrationRights Agreement
Registration Rights Agreements
PDL BIOPHARMA, INC.
2005
CO-DEVELOPMENT AND COMMERCIALIZATION AGREEMENT
PDL BIOPHARMA, INC.
2004
AMENDMENT NO. 1 TO SPECIAL COMPENSATION AND EMPLOYMENT AGREEMENT DATED MAY 1, 2002 BETWEEN LAURENCE JAY KORN AND PROTEIN DESIGNLABS, INC.
Compensation Agreements
PDL BIOPHARMA, INC.
2004
CONFIDENTIALPROVISIONS MARKED
PDL BIOPHARMA, INC.
2004
EXHIBIT10.46 (CONFIDENTIAL)
PDL BIOPHARMA, INC.
Biotechnology
2004
AMENDMENT NO. 1 TO THE HERCEPTINLICENSE AGREEMENT
PDL BIOPHARMA, INC.
Biotechnology
2004
CONFIDENTIAL PROVISIONS MARKED EXHIBIT 10.48 (CONFIDENTIAL)
PDL BIOPHARMA, INC.
2004
CONFIDENTIAL PROVISIONS MARKED EXHIBIT 10.49 (CONFIDENTIAL)
PDL BIOPHARMA, INC.
2004
Protein Design Labs, Inc. Retiree Health Care Plan Effective June 1, 2003
PDL BIOPHARMA, INC.
Biotechnology
CA
2004
Financial statements of businesses acquired
PDL BIOPHARMA, INC.
2003
Financial statements of businesses acquired
PDL BIOPHARMA, INC.
2003
Financial statements of businesses acquired
PDL BIOPHARMA, INC.
2003